Foul Smelling Compound may be a Remedy for Atherosclerosis

Putrid compound known for his foul smell may have a sweet side gig as atherosclerosis treatment, said researchers.

Putrescine the compound responsible for the foulest odor in nature, the smell of decomposing flesh may have a sweet side gig as a remedy for atherosclerosis and other chronic inflammatory diseases, according to a new study led by researchers at Columbia University Irving Medical Center.

This unusual discovery stems from an investigation into the body's process for removing dead cells using macrophages, a type of white blood cell that digests dead cells.

Atherosclerosis - Causes, Symptoms, Prevention & Treatment
Atherosclerosis is a condition in which the arteries become hard and narrow, leading to restricted blood flow.

‘Putrescine, the foul smelling compound could be used to treat atherosclerosis and other conditions characterized by chronic inflammation, such as Alzheimer's.’

"It's estimated that a billion cells die in the body every day, and if you don't get rid of them, they can cause inflammation and tissue death," says Ira Tabas, MD, PhD, the Richard J. Stock Professor of Medicine and professor of pathology & cell biology (in physiology & cellular biophysics) at Columbia University Vagelos College of Physicians and Surgeons. "Removing these dead cells by a process called 'efferocytosis' (from the Latin 'to carry to the grave') is one of the body's most important functions."

Normally, the process is initiated within minutes of cell death. However, studies have suggested that this essential housekeeping task is impaired in atherosclerosis, promoting the accumulation of plaques.

To learn more, Tabas, Arif Yurdagul Jr, PhD, associate research scientist in the Tabas lab, and colleagues set up human macrophages and dying cells in a dish and watched how the process unfolded.

Test Your Knowledge on Inflammation
We are uncomfortable when there is a skin injury or an insect bite and we notice the area becomes swollen, red, itchy and painful. These changes are part of the inflammatory response occurring to protect the body against or limit damage due to the external injurious agent. Take this quiz to test your knowledge on inflammation.

That's when they detected the role of putrescine. Macrophages, they found, reclaim arginine and other amino acids from the dead cells they engulf and use an enzyme to convert arginine into putrescine. Putrescine then activates a protein (Rac1) that signals the macrophages to eat more dead cells.

The results suggested atherosclerosis may be partly a putrescine problem, so the researchers turned to mice with atherosclerosis to investigate.

Long-term Air Pollution Exposure may Up Coronary Atherosclerosis Risk
Long-term exposure to particulate matter, nitrogen dioxide, as well as proximity to vehicular traffic, is linked to the plaque buildup in the artery walls leading to coronary atherosclerosis risk.

The researchers found that mice with worsening atherosclerosis had a short supply of putrescine because they didn't have enough of a key enzyme (arginase 1) to make the compound. "But when we put putrescine in the animals' drinking water, their macrophages got better at eating dead cells and the plaques improved."

But who would want to take a medicine that smells like rotting flesh?

Prediction of Atherosclerosis Risk Through a Blood Cell Marker
The appearance of sub-clinical atherosclerosis can be predicted by the identification of a molecule CD69 in blood cells, independant of classic cardiovascular diseases.

"Fortunately, when you dissolve putrescine into water, at least at the dosages needed to improve the plaques, it no longer gives off its odor. The mice drank it without any problem and show no signs of sickness," says Tabas, whose findings were published online Jan. 30 in the journal Cell Metabolism.

"Of course we do not yet know the feasibility and safety of using low-dose putrescine to ward off atherosclerotic heart disease and other diseases driven by defective efferocytosis. However, the study shows the potential of treating heart disease with compounds that help macrophages eat dead cells and that are currently in clinical trials for other indications."

Source-Eurekalert